Usona Identifies Controlled Crystal Engineering Process for Large-Scale Synthesis of Psilocybin Polymorphs
February 7, 2022
Crystallographic Discoveries Bring New Clarity to Pharmaceutical Psilocybin Polymorph Characterization
December 20, 2021
Usona Institute Breaks Ground for Global Center in Psychedelic Science
August 3, 2021
Usona Institute Publishes Synthesis and Characterization of cGMP 5-MeO-DMT
December 8, 2020
Usona Institute Publishes Breakthrough Development in Scalable Psilocybin Synthesis
August 3, 2020
FDA grants Breakthrough Therapy Designation to Usona Institute's psilocybin program for major depressive disorder
November 22, 2019
Usona Institute PSIL201 Study Site Now Recruiting Patients with Depression
October 24, 2019
Usona Institute Clinical Trial of Psilocybin for Major Depressive Disorder Launching This Fall
September 5, 2019
